Engineered PLGA Nanoparticles for Brain-Targeted Codelivery of Cannabidiol and pApoE2 through the Intranasal Route for the Treatment of Alzheimer’s Disease
ACS Biomaterials Science & Engineering · 2025
DOI: 10.1021/acsbiomaterials.5c00465 ↗Kurz gefasst
Fachartikel in der Zeitschrift ACS Biomaterials Science & Engineering, 2025. Verfasst von Arun Kumar Mahanta und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmaceutical Sciences, School of Pharmacy, College of Health and Human Sciences, North Dakota State University, Fargo, North Dakota 5…. Hauptthemen laut MEDLINE: Alzheimer Disease, Nanoparticles, Cannabidiol, Brain. Die Arbeit wurde bisher 10-mal zitiert (Crossref) und nennt 75 Literaturangaben. Gefördert von: NIA NIH HHS, National Institute on Aging.
Themen: Demenz
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Pharmaceutical Sciences, School of Pharmacy, College of Health and Human Sciences, North Dakota State University, Fargo, North Dakota 58108-6050, United States.
ORCID-Profile: Bivek Chaulagain, Jagdish Singh
Förderung
- NIA NIH HHS
- National Institute on Aging
Zitieren
APA
Mahanta, A. K., Chaulagain, B., Gothwal, A., & Singh, J. (2025). Engineered PLGA Nanoparticles for Brain-Targeted Codelivery of Cannabidiol and pApoE2 through the Intranasal Route for the Treatment of Alzheimer’s Disease. ACS Biomaterials Science & Engineering. https://doi.org/10.1021/acsbiomaterials.5c00465
Vancouver
Mahanta AK, Chaulagain B, Gothwal A, Singh J. Engineered PLGA Nanoparticles for Brain-Targeted Codelivery of Cannabidiol and pApoE2 through the Intranasal Route for the Treatment of Alzheimer’s Disease. ACS Biomaterials Science & Engineering. 2025. doi:10.1021/acsbiomaterials.5c00465
BibTeX
@article{Mahanta2025,
author = {Mahanta, Arun Kumar and Chaulagain, Bivek and Gothwal, Avinash and Singh, Jagdish},
title = {Engineered PLGA Nanoparticles for Brain-Targeted Codelivery of Cannabidiol and pApoE2 through the Intranasal Route for the Treatment of Alzheimer’s Disease},
journal = {ACS Biomaterials Science & Engineering},
year = {2025},
doi = {10.1021/acsbiomaterials.5c00465}
}
EUVIMED